stocks logo

OSUR

OraSure Technologies Inc
$
3.200
-0.08(-2.439%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.310
Open
3.310
VWAP
3.17
Vol
1.39M
Mkt Cap
239.36M
Low
3.105
Amount
4.39M
EV/EBITDA(TTM)
--
Total Shares
73.96M
EV
-8.06M
EV/OCF(TTM)
-8.93
P/S(TTM)
1.48
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests and sample management solutions. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
33.63M
-10.18%
--
--
33.97M
-14.89%
--
--
30.36M
-44.13%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for OraSure Technologies, Inc. (OSUR) for FY2025, with the revenue forecasts being adjusted by -3.52% over the past three months. During the same period, the stock price has changed by 11.50%.
Revenue Estimates for FY2025
Revise Downward
down Image
-3.52%
In Past 3 Month
Stock Price
Go Up
up Image
+11.50%
In Past 3 Month
1 Analyst Rating
down Image
-6.25% Downside
Wall Street analysts forecast OSUR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSUR is 3.00 USD with a low forecast of 3.00 USD and a high forecast of 3.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
down Image
-6.25% Downside
Current: 3.200
sliders
Low
3.00
Averages
3.00
High
3.00
Evercore ISI Group
Vijay Kumar
Hold
Maintains
$4.5 → $5
2024-08-07
Reason

Valuation Metrics

The current forward P/E ratio for OraSure Technologies Inc (OSUR.O) is -4.64, compared to its 5-year average forward P/E of -22.02. For a more detailed relative valuation and DCF analysis to assess OraSure Technologies Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-22.02
Current PE
-4.64
Overvalued PE
36.14
Undervalued PE
-80.19

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-24.50
Current EV/EBITDA
-0.49
Overvalued EV/EBITDA
188.74
Undervalued EV/EBITDA
-237.75

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.26
Current PS
1.90
Overvalued PS
3.39
Undervalued PS
1.14

Financials

Annual
Quarterly
FY2025Q1
YoY :
-44.71%
29.93M
Total Revenue
FY2025Q1
YoY :
+445.06%
-18.27M
Operating Profit
FY2025Q1
YoY :
+332.92%
-15.52M
Net Income after Tax
FY2025Q1
YoY :
+320.00%
-0.21
EPS - Diluted
FY2025Q1
YoY :
-490.64%
-20.15M
Free Cash Flow
FY2025Q1
YoY :
-6.73%
41.86
Gross Profit Margin - %
FY2025Q1
YoY :
-102.43%
-1.07
FCF Margin - %
FY2025Q1
YoY :
+709.52%
-53.59
Net Margin - %
FY2025Q1
N/A
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
6
761.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 2277.4% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
3.4M
Volume
1
6-9
Months
140.9K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

OSUR News & Events

Events Timeline

2025-07-14 (ET)
2025-07-14
12:13:08
Zwanziger offered $3.50-$4/share to buy OraSure, Reuters reports
select
link
2025-07-10 (ET)
2025-07-10
07:09:34
OraSure launches novel blood collection device for proteomic research
select
2025-05-19 (ET)
2025-05-19
11:30:19
Evercore says 23andMe buyout removes downside case for OraSure
select
Sign Up For More Events

News

8.5
07-14SeekingAlpha
Orasure gets takeover bid proposal from Ron Zwanziger- Reuters
5.0
07-10NASDAQ.COM
OraSure Launches Blood Collection Tube For High-Quality Proteomic Research
4.0
05-19Benzinga
Evercore ISI Group Maintains In-Line on OraSure Technologies, Maintains $3 Price Target
Sign Up For More News

FAQ

arrow icon

What is OraSure Technologies Inc (OSUR) stock price today?

The current price of OSUR is 3.2 USD — it has decreased -2.44 % in the last trading day.

arrow icon

What is OraSure Technologies Inc (OSUR)'s business?

arrow icon

What is the price predicton of OSUR Stock?

arrow icon

What is OraSure Technologies Inc (OSUR)'s revenue for the last quarter?

arrow icon

What is OraSure Technologies Inc (OSUR)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for OraSure Technologies Inc (OSUR)'s fundamentals?

arrow icon

How many employees does OraSure Technologies Inc (OSUR). have?

arrow icon

What is OraSure Technologies Inc (OSUR) market cap?